Loading...

PE anti-mouse CD103 Antibody

Pricing & Availability
Clone
2E7 (See other available formats)
Regulatory Status
RUO
Other Names
Integrin αIEL chain, Integrin αE chain, αE integrin, ITGAE
Isotype
Armenian Hamster IgG
Ave. Rating
Submit a Review
Product Citations
publications
2E7_PE_081908.jpg
C57BL/6 splenocytes stained with 2E7 PE
  • 2E7_PE_081908.jpg
    C57BL/6 splenocytes stained with 2E7 PE
Compare all formats See PE spectral data
Cat # Size Price Quantity Check Availability Save
121405 25 µg 59€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
121406 100 µg 176€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD103 is a type I transmembrane glycoprotein known as αE integrin or Integrin αIEL chain. It belongs to the integrin family and is primarily found on intestinal intraepithelial lymphocytes (IEL). CD103 is also expressed on a subpopulation of lamina propria T cells, epithelial dendritic cells, lamina propria-derived dendritic cells, and a small subset of peripheral lymphocytes. T regulatory cells express high level of CD103. The CD103 expression on lymphocytes can be induced upon activation and TGF-β stimulation. In association with integrin β7, CD103 is expressed as αE/β7 heterodimer. Mature CD103 protein can be cleaved into 2 chains, a 150 kD (C-terminal) chain and a 25 kD (N-terminal) chain, which remain linked by disulfide bonds. CD103 binds to E-cadherin and mediates homing of lymphocytes to the intestinal epithelium.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
Mouse intestinal intraepithelial lymphocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation1, immunohistochemical staining1,7 of acetone-fixed frozen sections, immunofluorescence2, and in vitro activation1.

Application References
  1. LeFrancois L, et. al, 1994. Eur. J. Immunol. 24:635. (FC, IHC, IP)
  2. Mysorekar IU, et. al, 2002. J. Biol. Chem. 277:37811. (FC, IF)
  3. Mikami N, et al. 2011. J. Immunol. 186:6886. PubMed
  4. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  5. Quinn KM, et al. 2013. J. Immunol. 191:5085. PubMed
  6. Verhagen J and Wraith DC. 2014. J. Immunol. Methods. S0022. (FC) PubMed
  7. Xiao B, et al. 2015. PLoS One 1:e0115333. (IHC)
Product Citations
  1. Oliver AJ, et al. 2020. Oncoimmunology. 9:1802979. PubMed
  2. Parsons M, et al. 2014. J Immunol. 192:1361. PubMed
  3. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  4. Bruand M, et al. 2021. Cell Reports. 36(3):109412. PubMed
  5. Ramakrishna C, et al. 2019. Nat Commun. 10:2153. PubMed
  6. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  7. Gonalves S, et al. 2021. Cell Reports. 34(11):108860. PubMed
  8. Kim S, et al. 2020. Immunity. 53(4):759-774.e9. PubMed
  9. Rezende R, et al. 2015. Nat Commun. 6: 8726. PubMed
  10. Vogel AJ et al. 2015. Frontiers in immunology. 0.477083333 . PubMed
  11. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  12. Barry KC, et al. 2018. Nat Med. 24:1178. PubMed
  13. Devalaraja S, et al. 2020. Cell. 1098:180. PubMed
  14. Tordesillas L, et al. 2018. Nat Commun. 9:5238. PubMed
  15. Vereertbrugghen A, et al. 2021. Front Oncol. 11:598319. PubMed
  16. Wang C, et al. 2021. Cell Rep. 37:110021. PubMed
  17. Hao F, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  18. Yu AI, et al. 2020. Cell Rep. 107471:31. PubMed
  19. Blankenhaus B, et al. 2014. PLoS Pathog. 10:1003913. PubMed
  20. Best SA, et al. 2018. Cell Metab. 27:935. PubMed
  21. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  22. Stump CT, et al. 2021. Open Biol. 11:210245. PubMed
  23. Wang Y, et al. 2021. Sci Rep. 1.429861111. PubMed
  24. Hartwig T et al. 2018. Cell reports. 25(13):3564-3572 . PubMed
  25. Hulsmans M et al. 2017. Cell. 169(3):510-522 . PubMed
  26. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  27. Crooks SD, et al. 2022. Immunohorizons. 6:705. PubMed
  28. Ahadome S, et al. 2016. JCI Insight. 1:e87012. PubMed
  29. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  30. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  31. Van Braeckel-Budimir N, et al. 2018. Cell Rep. 24:3374. PubMed
  32. De Ponte Conti B, et al. 2021. Elife. 10:. PubMed
  33. Murakami R, et al. 2013. PLoS One. 8:73270. PubMed
  34. Kyburz A, et al. 2019. J Allergy Clin Immunol. 143:1496. PubMed
  35. Tuong ZK, et al. 2021. iScience. 24:103326. PubMed
  36. Guo S, et al. 2021. Sci Rep. 11:23745. PubMed
  37. Chandra J, et al. 2016. Immunol Cell Biol. 10.1038/icb.2016.83. PubMed
  38. Alam Z, et al. 2020. Cell Rep. 107825:31. PubMed
  39. Beura LK, et al. 2018. Immunity. 48:327. PubMed
  40. Katagiri T, et al. 2019. Mucosal Immunol. 12:p1104. PubMed
  41. Stephens WZ, et al. 2021. Cell Rep. 37:109916. PubMed
  42. Zhang XW, et al. 2021. Oncoimmunology. 10:1920739. PubMed
  43. Nelson CE et al. 2019. Cell Rep. 28(12):3092-3104 . PubMed
  44. Carlson PM, et al. 2021. J Immunol. 207:720. PubMed
  45. Calderon B, et al. 2015. J Exp Med. 212: 1497-1512. PubMed
  46. Keerthivasan S, et al. 2021. Immunity. 54(7):1511-1526.e8. PubMed
  47. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  48. Lee HY, et al. 2021. Curr Protoc. 1:e272. PubMed
  49. Yamazaki S, et al. 2015. J Immunol. 195: 3427 - 3435. PubMed
  50. Bonavita E, et al. 2020. Immunity. 1215:53. PubMed
  51. Wan X, Thomas J, Unanue E 2016. J Exp Med. 213: 967 - 978. PubMed
  52. Jin J, et al. 2020. Cell Reports. 30(12):4124-4136. PubMed
  53. Tran S, et al. 2020. Immunity. 53(3):627-640.e5. PubMed
  54. Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed
  55. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  56. Chang MH, et al. 2021. Cell Rep. 37:109902. PubMed
  57. Guo S, et al. 2021. Frontiers in Immunology. 11:614667. PubMed
  58. Thomson CA, et al. 2018. J Immunol. 201:215. PubMed
RRID
AB_535948 (BioLegend Cat. No. 121405)
AB_1133989 (BioLegend Cat. No. 121406)

Antigen Details

Structure
Type I transmembrane glycoprotein, Integrin family, can be cleaved into 150 kD and 25 kD chains, associated with β7 integrin
Distribution

Majority of intestinal intraepithelial lymphocytes (IEL), subpopulation of lamina propria T cells, epithelial dendritic cells, small subset of peripheral lymphocytes, Treg cells.

Function
Retention and activation of CD103+ lymphocytes in the intestinal epithelium, regulate tissue-specific T cell homing.
Ligand/Receptor
E-Cadherin
Cell Type
Dendritic cells, Lymphocytes, T cells, Tregs
Biology Area
Immunology
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Kilshaw PJ and SJ. Murant. 1990. Eur. J. Immunol. 20:2201.
2. Karecla PI, et al. 1995. Eur. J. Immunol. 25:852.
3. LeFrancois L, et al. 1994. Eur. J. Immunol. 24:635.
4. Sung SS, et al. 2006. J. Immunol. 176:2161.
5. Johansson-Lindbom B, et al. 2005. J. Exp. Med. 202:1063.
6. Dujardin HC, et al. 2004. Proc. Natl. Acad. Sci. USA. 101:14473.

Gene ID
16407 View all products for this Gene ID
UniProt
View information about CD103 on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.
Go To Top Version: 2    Revision Date: 05/04/2015

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account